Nai Francesco, Flores Espinoza Maria Paula, Invernizzi Annalisa, Vargas-Rosales Pablo Andrés, Bobileva Olga, Herok Marcin, Caflisch Amedeo
Department of Biochemistry, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland.
Latvian Institute of Organic Synthesis, Aizkraukles 21, Riga LV-1006, Latvia.
ACS Bio Med Chem Au. 2023 Dec 12;4(2):100-110. doi: 10.1021/acsbiomedchemau.3c00030. eCollection 2024 Apr 17.
We discovered the first inhibitors of the m7G-RNA writer METTL1 by high-throughput docking and an enzymatic assay based on luminescence. Eleven compounds, which belong to three different chemotypes, show inhibitory activity in the range 40-300 μM. Two adenine derivatives identified by docking have very favorable ligand efficiency of 0.34 and 0.31 kcal/mol per non-hydrogen atom, respectively. Molecular dynamics simulations provide evidence that the inhibitors compete with the binding of the cosubstrate -adenosyl methionine to METTL1. We also present a soakable crystal form that was used to determine the structure of the complex of METTL1 with sinefungin at a resolution of 1.85 Å.
我们通过高通量对接和基于发光的酶促测定法发现了m7G-RNA写入酶METTL1的首批抑制剂。属于三种不同化学类型的11种化合物在40-300μM范围内显示出抑制活性。通过对接鉴定出的两种腺嘌呤衍生物分别具有非常有利的配体效率,每个非氢原子的配体效率为0.34和0.31 kcal/mol。分子动力学模拟提供了证据,表明这些抑制剂与共底物S-腺苷甲硫氨酸与METTL1的结合相互竞争。我们还展示了一种可用于浸泡的晶体形式,该晶体形式用于以1.85 Å的分辨率确定METTL1与杀稻瘟菌素的复合物结构。